Investor profile
Ahren Innovation Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Ahren Innovation Capital is a deep tech and deep science investment institution that supports transformational companies at the intersection of ground-breaking science and highest-end technology. The firm focuses on four broad domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy — believing wholeheartedly that the future will be cross-domain. Ahren partners with stellar founders and teams at all stages from pre-seed to pre-IPO, providing both patient and active capital to exceptional founders and empowering them to achieve the unimaginable. Founded in 2017 by Alice Newcombe-Ellis alongside co-founding Science Partners whose combined technologies are valued in excess of $100BN, Ahren's model is a genuine partnership between the creators of deep technology and deep science and commercially active, long-term capital. The firm takes asymmetric, considered risk to deliver superior rewards — capturing a generational opportunity to provide smart capital to deep technology — while also leveraging Strategic LP Partnerships and a network of world-class scientists, including Nobel laureates, to support portfolio companies.
Notable quotes
“Our mission is to invest in transformational companies that will change the world for the better, serving vast markets. We believe that Rubedo's transformative approach to targeting senescent cells is an impressive step towards the development of chronic age-related therapies, which will advance biotech from treatment to prevention or disease reversal.”
“Ahren's strategy has an overarching theme: to invest at the intersection of deep tech and deep science in opportunities that are transformational and highly commercial. That intersection is an operative word: we believe wholeheartedly that the future will be cross-domain.”
“PS we are investing from our latest fund and have >$400m in dry powder, please feel free to get in touch.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Graphcore | Series D / Series E | $222m | 2021-01-01 |
| AI21 Labs | Series C | $208m | 2023-08-01 |
| Bicycle Therapeutics | Series B | — | 2019-01-01 |
| Heirloom Carbon | Series B | $150m | 2024-12-04 |
| Constructive Bio | Series A | $58m | 2024-09-01 |
| Nu Quantum | Series A | $60m | 2025-12-10 |
| OutSee | Seed | $3m | 2026-01-12 |
| ZOE | Series B | — | 2021-01-01 |
| Rubedo Life Sciences | Series A | $40m | 2022-02-01 |
| Phaidra | Series A | — | 2022-01-01 |
Frequent co-investors
Fit check
Is Ahren Innovation Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit